NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jun 2, 2015
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Sale
Common Stock
2015-06-01$1.24/sh−12,500$15,538→ 297,237 total
Footnotes (2)
- [F1]Sales effected pursuant to a 10b5-1 trading plan adopted by Mr. Larson on March 13, 2015.
- [F2]Weighted average of sales prices ranging from $1.23 to $1.29 per share. Mr. Larson undertakes to provide upon request by the Staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.